Non-invasive assessment of portal hypertension by multi-parametric magnetic resonance imaging of the spleen: a proof of concept study

Non-invasive assessment of portal hypertension by multi-parametric magnetic resonance imaging of the spleen: a proof of concept study

<p><strong>Background and aims</strong></p> <p>Non-invasive assessment of portal hypertension is an area of unmet need. This proof of concept study aimed to evaluate the diagnostic accuracy of a multi-parametric magnetic resonance technique in the assessment of portal h...

Descripció completa

Dades bibliogràfiques
Autors principals:	Levick, C, Phillips-Hughes, J, Collier, J, Banerjee, R, Cobbold, JF, Wang, LM, Piechnik, SK, Robson, MD, Neubauer, S, Barnes, E, Pavlides, M
Format:	Journal article
Idioma:	English
Publicat:	Public Library of Science 2019

Ítems similars

Spleen extracellular volume fraction and platelet count/spleen volume ratio are accurate non-invasive markers of portal hypertension
per: Levick, C, et al.
Publicat: (2019)

Spleen T1 and spleen diameter criteria can identify and exclude oesophageal varices accurately
per: Levick, C, et al.
Publicat: (2019)

Platelet and spleen volume criteria exclude more oesophageal varices needing treatment than Baveno VI criteria with 100% sensitivity
per: Levick, C, et al.
Publicat: (2018)

Multi-parametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease severity
per: Pavlides, M, et al.
Publicat: (2017)

Liver function assessment using magnetic resonance imaging with gadoxetic acid administration
per: Levick, C, et al.
Publicat: (2018)

Multi-parametric MRI can diagnose steatohepatitis and cirrhosis in patients with NAFLD
per: Pavlides, M, et al.
Publicat: (2014)

Multi-parametric MRI predicts clinical outcomes in unselected patients with liver disease - a non-invasive test that meets the AASLD criteria for clinical trials?
per: Pavlides, M, et al.
Publicat: (2014)

Magnetic resonance assessment of portal hypertension and liver function
per: Levick, C
Publicat: (2019)

HYSTOMETRIA OF SPLEEN AND PORTAL VEINS IN NORMAL AND AT SYNDROME PORTAL HYPERTENSION IN AGE ASPECTS
per: N. V. GETMAN
Publicat: (2017-06-01)

A community of portal hypertension
per: Qi, X, et al.
Publicat: (2021)

Prognostic value of multiparametric magnetic resonance imaging, transient elastography and blood‐based fibrosis markers in patients with chronic liver disease
per: Jayaswal, ANA, et al.
Publicat: (2020)

The Value of Liver and Spleen Stiffness for Evaluation of Portal Hypertension in Compensated Cirrhosis
per: Thomas Reiberger
Publicat: (2022-05-01)

Increased immunohistochemical expression of YKL-40 in the spleen of patients with portal hypertension
per: Dong Wang, et al.
Publicat: (2012-03-01)

Quantifying the heterogeneity of liver inflammation and fibrosis in primary sclerosing cholangitis using the interquartile range of iron‐corrected T1 from multi‐parametric MRI
per: Selvaraj, E, et al.
Publicat: (2019)

Spleen stiffness measurement as a non-invasive assessment in patients with portal hypertension
per: Jie Li, et al.
Publicat: (2024-02-01)

Phosphodiester content measured in human liver by in vivo (31) P MR spectroscopy at 7 tesla.
per: Purvis, L, et al.
Publicat: (2017)

Liver cT1 decreases following direct acting antiviral therapy in patients with chronic hepatitis C virus
per: Jayaswal, A, et al.
Publicat: (2020)

Spleen bed laparoscopic splenectomy plus pericardial devascularization for elderly patients with portal hypertension
per: Cao Yan, et al.
Publicat: (2022-03-01)

Case series: Gamna-Gandy bodies of the spleen: A supportive finding for portal hypertension
per: Ahmet Mesrur Halefoglu
Publicat: (2007-07-01)

Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease
per: Pavlides, M, et al.
Publicat: (2015)

Liver and Spleen Stiffness Measurements for Assessment of Portal Hypertension Severity in Patients with Budd Chiari Syndrome
per: Elton Dajti, et al.
Publicat: (2019-01-01)

Detection of liver and spleen stiffness in rats with portal hypertension by two-dimensional shear wave elastography
per: YongJian Chen, et al.
Publicat: (2022-04-01)

Spleen stiffness can be employed to assess the efficacy of spontaneous portosystemic shunts in relieving portal hypertension
per: Mauro Giuffrè, et al.
Publicat: (2020-11-01)

T2*magnetic resonance imaging is more sensitive than histology and serum ferritin for the assessment of iron overload in patients with NAFLD
per: Pavlides, M, et al.
Publicat: (2014)

Spleen and Liver Volumetrics as Surrogate Markers of Hepatic Venous Pressure Gradient in Patients With Noncirrhotic Portal Hypertension
per: Ohad Etzion, et al.
Publicat: (2018-08-01)

Spleen Stiffness on Magnetic Resonance Elastography for the Detection of Portal Hypertension: A Systematic Review and Meta-Analysis
per: Ma Yiyi, et al.
Publicat: (2022-09-01)

Risk of hepatocellular carcinoma after HCV eradication: Determining the role of portal hypertension by measuring spleen stiffness
per: Elton Dajti, et al.
Publicat: (2021-06-01)

Differentiation and migration of bone marrow mesenchymal stem cells transplanted through the spleen in rats with portal hypertension.
per: Song Sun, et al.
Publicat: (2013-01-01)

Reply to: "Multiparametric magnetic resonance imaging to predict clinical outcomes in patients with chronic liver disease: a cautionary note on a promising technique".
per: Pavlides, M, et al.
Publicat: (2016)

Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease.
per: Banerjee, R, et al.
Publicat: (2014)

Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease
per: Banerjee, R, et al.
Publicat: (2014)

CT-derived liver and spleen volume accurately diagnose clinically significant portal hypertension in patients with hepatocellular carcinoma
per: Mario Romero-Cristóbal, et al.
Publicat: (2023-03-01)

Mitra shunt (spleen preserving, side to side lieno-renal shunt) for portal hypertension with hypersplenism in early infancy
per: Sangram Shinde, et al.
Publicat: (2014-01-01)

Continuous quantitative mapping of multi-organ T1 relaxation times with ShMOLLI to assess dose response in respiratory challenges at 3T
per: Piechnik SK, et al.
Publicat: (2013-01-01)

Correlation between portal vein diameter and craniocaudal length of the spleen
per: Shah Zaman, et al.
Publicat: (2019-12-01)

Spleen and Liver Stiffness Evaluation by ARFI Imaging: A Reliable Tool for a Short-Term Monitoring of Portal Hypertension?
per: Andreas Binzberger, et al.
Publicat: (2022-01-01)

After A Year of Follow Up Non-Cirrhotic Portal Hypertension Patient with Partial Spleen Embolization (PSE) Management
per: Akhmadu Muradi, et al.
Publicat: (2022-01-01)

Partial spleen embolization reduces the risk of portal hypertension-induced upper gastrointestinal bleeding in patients not eligible for TIPS implantation.
per: Matthias Buechter, et al.
Publicat: (2017-01-01)

An imaging-based artificial intelligence model for non-invasive grading of hepatic venous pressure gradient in cirrhotic portal hypertension
per: Yu, Q, et al.
Publicat: (2022)

Non-alcoholic fatty liver disease
per: Pavlides, M, et al.
Publicat: (2019)